# Cilostazol (Cilostazol)

Source: https://ourhealthnetwork.com/drugs/cilostazol
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Cilostazol?

Cilostazol is a phosphodiesterase 3 inhibitor. It is prescribed to treat peripheral vascular diseases, intermittent claudication, graft occlusion. Across the United States, 18,000 doctors prescribe Cilostazol to approximately 75,000 Medicare patients.

## Brand names

Cilostazol

## Indications

Cilostazol is prescribed for several conditions including peripheral vascular diseases, intermittent claudication, graft occlusion, among others.

## Conditions treated

- [Peripheral Vascular Diseases](https://ourhealthnetwork.com/conditions/peripheral-vascular-diseases)
- [Intermittent Claudication](https://ourhealthnetwork.com/conditions/intermittent-claudication)
- [Graft Occlusion](https://ourhealthnetwork.com/conditions/graft-occlusion)
- [Vascular](https://ourhealthnetwork.com/conditions/vascular)

## Mechanism of action

improving blood flow to the legs

## Drug classification

- Established Pharmacologic Class: Phosphodiesterase 3 Inhibitor [EPC]
- Mechanism of Action class: Phosphodiesterase 3 Inhibitors [MoA]
- Route of administration: ORAL

## Common side effects

mg twice daily

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)